1.A magnetism/laser-auxiliary cascaded drug delivery to pulmonary carcinoma.
Jialiang LIN ; Qingqing YIN ; Binlong CHEN ; Haoran ZHANG ; Dong MEI ; Jijun FU ; Bing HE ; Hua ZHANG ; Wenbing DAI ; Xueqing WANG ; Yiguang WANG ; Qiang ZHANG
Acta Pharmaceutica Sinica B 2020;10(8):1549-1562
Although high-efficiency targeted delivery is investigated for years, the efficiency of tumor targeting seems still a hard core to smash. To overcome this problem, we design a three-step delivery strategy based on streptavidin-biotin interaction with the help of c(RGDfK), magnetic fields and lasers. The ultrasmall superparamagnetic iron oxide nanoparticles (USIONPs) modified with c(RGDfK) and biotin are delivered at step 1, followed by streptavidin and the doxorubicin (Dox) loaded nanosystems conjugated with biotin at steps 2 and 3, respectively. The delivery systems were proved to be efficient on A549 cells. The co-localization of signal for each step revealed the targeting mechanism. The external magnetic field could further amplify the endocytosis of USPIONs based on c(RGDfK), and magnify the uptake distinctions among different test groups. Based on photoacoustic imaging, laser-heating treatment could enhance the permeability of tumor venous blood vessels and change the insufficient blood flow in cancer. Then, it was noticed that only three-step delivery with laser-heating and magnetic fields realized the highest tumor distribution of nanosystem. Finally, the magnetism/laser-auxiliary cascaded delivery exhibited the best antitumor efficacy. Generally, this study demonstrated the necessity of combining physical, biological and chemical means of targeting.
2.Erratum: Author correction to 'Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer' Acta Pharmaceutica Sinica B 2019; 9(5):1061-1077.
Dong MEI ; Binlong CHEN ; Bing HE ; Haibin LIU ; Zhiqiang LIN ; Jialiang LIN ; Xiaoyan ZHANG ; Ning SUN ; Libo ZHAO ; Xiaoling WANG ; Qiang ZHANG
Acta Pharmaceutica Sinica B 2020;10(6):1143-1144
[This corrects the article DOI: 10.1016/j.apsb.2019.03.006.].
3.Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer.
Dong MEI ; Binlong CHEN ; Bing HE ; Haibin LIU ; Zhiqiang LIN ; Jialiang LIN ; Xiaoyan ZHANG ; Ning SUN ; Libo ZHAO ; Xiaoling WANG ; Qiang ZHANG
Acta Pharmaceutica Sinica B 2019;9(5):1061-1077
Recently, considerable attention in the field of cancer therapy has been focused on the mammalian rapamycin target (mTOR), inhibition of which could result in autophagic cell death (ACD). Though novel combination chemotherapy of autophagy inducers with chemotherapeutic agents is extensively investigated, nanomedicine-based combination therapy for ACD remains in infancy. In attempt to actively trigger ACD for synergistic chemotherapy, here we incorporated autophagy inducer rapamycin (RAP) into 7pep-modified PEG-DSPE polymer micelles (7pep-M-RAP) to specifically target and efficiently priming ACD of MCF-7 human breast cancer cells with high expression of transferrin receptor (TfR). Cytotoxic paclitaxel (PTX)-loaded micelle (7pep-M-PTX) was regarded as chemotherapeutic drug model. We discovered that with superior intracellular uptake and more tumor accumulation of micelles , 7pep-M-RAP exhibited excellent autophagy induction and synergistic antitumor efficacy with 7pep-M-PTX. Mechanism study further revealed that 7pep-M-RAP and 7pep-M-PTX used in combination provided enhanced efficacy through induction of both apoptosis- and mitochondria-associated autophagic cell death. Together, our findings suggested that the targeted excess autophagy may provide a rational strategy to improve therapeutic outcome of breast cancer, and simultaneous induction of ACD and apoptosis may be a promising anticancer modality.